Literature DB >> 29076408

Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.

Rita Citraro1, Antonio Leo1, Matteo Santoro2, Giuseppe D'agostino3, Andrew Constanti4, Emilio Russo1.   

Abstract

BACKGROUND: Emerging evidence suggests that epigenetic mechanisms are involved in different brain functions such as the development of the nervous system and normal neuronal function. At the same time, it has been proposed that several neurological diseases are in part, caused by aberrant epigenetic modifications. Nevertheless, the mechanisms underlying pathological alterations in the brain genome are not completely understood. METHODS AND
RESULTS: Post-transcriptional histone acetylation is a major mechanism of chromatin remodeling, contributing to epigenetic regulation of gene transcription. Histone deacetylases (HDACs) are a family of proteins involved in both physiological and pathological conditions by regulating the status of chromatin histone acetylation. It is now becoming clear that epigenetic regulatory mechanisms may also play a major role in epilepsy; modulation of chromatin structure through histone modifications has emerged as an important regulator of gene transcription in the brain and altered histone acetylation seems to contribute to changes in gene expression associated with epilepsy and the epileptogenic process. Histone modification is crucial for regulating neurobiological processes such as neural network function, synaptic plasticity, and synaptogenesis which also contribute to the pathophysiology of epilepsy.
CONCLUSIONS: The role of epigenetics in epilepsy development is a new and emerging research area; the present article reviews the recent findings on the role played by HDACs and the possible function of different histone modifications in epilepsy and epileptogenesis. Inhibitors of HDACs (HDACIs) have been tested in different experimental models of epilepsy with some success. We also review the results from these studies, which indicate HDACIs as potential new therapeutic agents for the treatment of human epilepsy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Epigenetics; brainzzm321990disorders.; chromatin; epilepsy; epileptogenesis; histone deacetylase (HDAC); histone deacetylase inhibitors (HDACIs)

Mesh:

Substances:

Year:  2017        PMID: 29076408     DOI: 10.2174/1381612823666171024130001

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

Review 2.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

3.  Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery.

Authors:  Yifan Zhang; Lise Heylen; Michèle Partoens; James D Mills; Rafal M Kaminski; Patrice Godard; Michel Gillard; Peter A M de Witte; Aleksandra Siekierska
Journal:  Front Mol Neurosci       Date:  2022-05-24       Impact factor: 6.261

Review 4.  Adenosine kinase: A key regulator of purinergic physiology.

Authors:  Detlev Boison; Michael F Jarvis
Journal:  Biochem Pharmacol       Date:  2020-11-06       Impact factor: 5.858

5.  Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Authors:  Arpna Srivastava; Jyotirmoy Banerjee; Vivek Dubey; Manjari Tripathi; P Sarat Chandra; M C Sharma; Sanjeev Lalwani; Fouzia Siraj; Ramesh Doddamani; Aparna Banerjee Dixit
Journal:  Cell Mol Neurobiol       Date:  2020-11-28       Impact factor: 5.046

6.  Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy.

Authors:  Carmen De Caro; Antonio Leo; Valentina Nesci; Carla Ghelardini; Lorenzo di Cesare Mannelli; Pasquale Striano; Carmen Avagliano; Antonio Calignano; Paolo Mainardi; Andrew Constanti; Rita Citraro; Giovambattista De Sarro; Emilio Russo
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

7.  Pain Modulation in WAG/Rij Epileptic Rats (A Genetic Model of Absence Epilepsy): Effects of Biological and Pharmacological Histone Deacetylase Inhibitors.

Authors:  Carmen De Caro; Lorenzo Di Cesare Mannelli; Jacopo Junio Valerio Branca; Laura Micheli; Rita Citraro; Emilio Russo; Giovambattista De Sarro; Carla Ghelardini; Antonio Calignano; Roberto Russo
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

8.  The GABRG2 F343L allele causes spontaneous seizures in a novel transgenic zebrafish model that can be treated with suberanilohydroxamic acid (SAHA).

Authors:  Dingding Shen; Juan Chen; Dong Liu; Mi Shen; Xin Wang; Youjia Wu; Shuan Ke; Robert L Macdonald; Qi Zhang
Journal:  Ann Transl Med       Date:  2020-12

9.  Whole genomic approach in mutation discovery of infantile spasms patients.

Authors:  Seungbok Lee; Sesong Jang; Jong-Il Kim; Jong Hee Chae; Ki Joong Kim; Byung Chan Lim
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.